Bernd Bokemeyer

26PUBLICATIONS

73CO-AUTHORS

Epidemiological methodsGene expression (incl. microarray and other genome-wide approaches)Work integrated learning (incl. internships)Immunogenetics (incl. genetic immunology)Cross-sectional analysis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (26)

Sort by Publication Date:

|Jun 15, 2026

Comparative Real-World Effectiveness of Anti-TNF, Ustekinumab and Vedolizumab in Crohn's Disease Over 24 Months: A Pooled Analysis From the Prospective UMBRELLA-IBD Registry in Germany.

|May 25, 2026

Exome sequencing directly implicates 68 genes in inflammatory bowel disease.

|Apr 03, 2026

Competence network inflammatory bowel diseases in Germany: 25 years of interdisciplinary and cross-sectoral research and knowledge transfer across all levels of IBD care.

Bernd Bokemeyer, Sandra Plachta-Danielzik, Ulf Helwig

|Oct 29, 2025

Real-World Effectiveness of Golimumab in Ulcerative Colitis: A Pooled Analysis from the Prospective UMBRELLA-IBD Registry in Germany.

Arne Bokemeyer, Thomas Wenske, Sandra Plachta-Danielzik

|Oct 17, 2025

Healthcare resource utilization and cost in pediatric celiac disease: A case-control study using German insurance data.

Sibylle Koletzko, Svitlana Schnaidt, Leonarda Serdani-Neuhaus

|Aug 25, 2025

Author response to "Comment on: Burden of coeliac disease in Germany: real world insights from a large retrospective health insurance claims database analysis".

Bernd Bokemeyer, Leonarda Serdani-Neuhaus, Juliane Sünwoldt

Pageof 5

Frequent Collaborators

4 joint publications

Niels Teich

4 joint publications

Sandra Plachta-Danielzik

Svitlana Schnaidt

Stefan Schreiber

Arne Bokemeyer

Thomas Wenske

Stefan Schreiber

B Deiters

F Hardtstock

H D Orzechowski

Frequent Collaborators

4 joint publications

Niels Teich

4 joint publications

Sandra Plachta-Danielzik

3 joint publications

Svitlana Schnaidt

3 joint publications

Stefan Schreiber